Respiratory disease in Europe

report on a study. by John Richard Thomas Colley

Publisher: Regional Office for Europe, World Health Organisation in Copenhagen

Written in English
Published: Pages: 43 Downloads: 290
Share This


  • Europe


  • Respiratory organs -- Diseases -- Europe -- Statistics.

Edition Notes

SeriesEURO ; 4905 (5)
ContributionsWorld Health Organization.
LC ClassificationsRC732 .C62
The Physical Object
Paginationiii, 43 p. :
Number of Pages43
ID Numbers
Open LibraryOL4277355M
LC Control Number78303073

Orphan lung diseases differ from the more common pulmonary disorders, due to the fact that the respiratory physician will only see a few of them each year or even during their career. However, as a specialist, it is necessary to identify and confirm such a diagnosis in a patient. This Monograph comprehensively covers the most common and/or complex of these orphan lung Cited by: Coronavirus disease (COVID) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was first identified in December in Wuhan, China, and has since spread globally, resulting in an ongoing pandemic. As of 14 May , more than million cases have been reported across countries and territories, . Overview. A wide variety of health events ranging in severity may occur related to air transport, requiring different responses or, perhaps, no response at all. Respiratory Complaints. Respiratory complaints are frequent among returned travelers and are typically associated with common respiratory viruses (see Chapter 2, Respiratory Infections). Influenza is the most common vaccine-preventable disease associated with international travel.

Respiratory disease caused by BRSV was first reported in Europe during the s and has been recognized throughout the United States since the s in endemic form in beef and dairy cattle. Observations from both experimental and natural disease have been reported, and it is now accepted that BRSV was likely the cause of many poorly defined. respiratory patients, showed that the proportion of patients with respiratory symptoms, among those over 5 years of age, who visited primary health care centres ranged from % to % (Table 5). Chronic respiratory disease Year of estimation Prevalence Reference Asthma million 15 Chronic obstructive pulmonary disease The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.   Graeme P. Currie Published by Oxford University Press, UK Pages: Price: £ ISBN: ‐0‐19‐‐5 Chronic Obstructive Pulmonary Disease (COPD), by Graeme P. Currie, has been published as part of “The Facts” series from Oxford University Press (UK), which is intended to offer practical advice about an illness or a condition in a clear and easy to Author: E. Weitzenblum.

The ERS COVID resource centre brings together all European Respiratory Society (ERS) and European Lung Foundation (ELF) resources on SARS-CoV-2 and COVID as it is published. ERS is committed to supporting health workers during these challenging times by providing up-to-date information and a variety of educational resources, all of which. This study examines mortality and morbidity data on respiratory diseases for certain countries in Europe. 26 countries, all but 3 of which used the Eighth Revision of the International Classification of Diseases, were ranked according to age and sex specific rates of death from pneumonia and bronchitis in or Northern mainland countries had the lowest rates for infants and . Nunn's Applied Respiratory Physiology, Seventh Edition covers all aspects of respiratory physiology in health, disease, and altered conditions and environments, from basic science to clinical applications. Includes functional anatomy, mechanics, control of breathing, ventilation, circulation, ventilation-perfusion matching, diffusion, carbon dioxide and oxygen, and non . It is the most important etiological agent of bovine mycoplasmoses in North America and Europe, causing respiratory disease, mastitis, otitis media, arthritis, and reproductive : Lloyd Reeve-Johnson.

Respiratory disease in Europe by John Richard Thomas Colley Download PDF EPUB FB2

The European Respiratory Society’s White Book is a landmark overview of lung health in Europe. The burden of lung disease. More than half of all the deaths from lung disease in Europe, and at least one-quarter of all respiratory hospital admissions, are due to diseases caused by smoking.

10 years have passed since the European Lung White Book – The first comprehensive survey on respiratory lung health in Europe was published by the European Respiratory Society (ERS) together with the European Lung Foundation (ELF) [].Its aims were to highlight the enormous and underestimated health and socioeconomic burdens of respiratory Cited by: disease (COPD), lung cancer and tuberculosis) exceeded that due to cardio- and cerebrovascular disease.

The White Book also detailed, for the first time, the financial impact of respiratory disease across the whole of Europe (i.e. the European region as defined by the WHO) with direct and indirect health costs estimated to exceed J by: 1. Eur Respir J. Sep;42(3) doi: / Respiratory health and disease in Europe: the new European Lung White by: The proportion of deaths due to respiratory disease was higher among the 28 countries of the European Union (EU28) % ( deaths annually) - than among the remainder of the WHO European countries, where it was % ( deaths annually).

Respiratory health and disease in Europe: The new European Lung White Book Article (PDF Available) in European Respiratory Journal 42(3) September with Reads How we measure 'reads'.

The European Respiratory Society (ERS) and European Lung Foundation (ELF) “Lung Health in Europe Facts and Figures” provides an accessible and reliable summary of the state of lung health in Europe.

At a fi rst glance, the problems appear insurmountable. Respiratory disease causes about 1 million deaths. Respiratory disease in Europe book, smoking tobacco is the main cause of lung disease in Europe (note that the data presented in this article do not cover cancer), while it is also considered to be a major contributory factor to the incidence of chronic obstructive pulmonary disease (COPD) and the development of asthma in children and adults; furthermore, respiratory.

The European Lung White Book is a comprehensive publication highlighting the impact of lung diseases in Europe, published by the European Respiratory Society. The European Lung Foundation have produced a concise version of this publication containing the key facts and figures in easy-to-understand infographics and a free slideset to help you.

of lung health and disease in Europe as it stands and an informed analysis of future trends. Covering risk factors, the major diseases, the development of the various fields of respiratory medicine and training and the growth of patient support organisations, the book lays out a series of policy recommendations to ensure a brighter, better.

In the WHO-defined European region, one in ten deaths are caused by either chronic obstructive pulmonary disease (COPD), lung cancer, tuberculosis, or a lower respiratory tract infection such as pneumonia.

This is the major headline from The European Lung White Book, released by the European Respiratory Society at the annual congress on Sept 6, About the ERS Monograph. The ERS Monograph is the quarterly book series published by the European Respiratory Society (ERS).Each Monograph provides a comprehensive overview of one clinical area of respiratory health, communicating information about the most advanced techniques and systems required for its provides up-to-date and useful.

Published by the European Respiratory Society, the European Lung White Book draws on the latest data from the World Health Organization and European Centre for Disease Prevention and Control and input from experts across the continent to present a rigorous examination of lung health and disease in Europe as it stands and an informed analysis of future trends.

Chronic respiratory diseases They also have large adverse economic effects on families, communities and societies in general. WHO/Europe aims to support Member States in their efforts to reduce the toll of morbidity, disability and premature mortality related to chronic respiratory diseases.

Respiratory Disease and Infection. Respiratory disease is a medical term that encompasses pathological conditions affecting the organs and tissues that make gas exchange possible in higher organisms, and includes conditions of the upper respiratory tract, trachea, bronchi, bronchioles, alveoli, pleura and pleural cavity, and the nerves and muscles of breathing.

Clinical Manifestations & Assessment of Respiratory Disease - E-Book Terry Des Jardins. out of 5 stars Kindle Edition. $ Egan's Fundamentals of Respiratory Care - E-Book Robert M. Kacmarek. out of 5 stars Kindle Edition. $/5(14). The European Respiratory Review (ERR) is an open access journal published quarterly by the European Respiratory Society (ERS), providing an Read online The ERS Monograph is the quarterly book series from the European Respiratory Society.

According to the latest available data for –, over 12% of infant deaths in the Region are due to respiratory diseases.

In general, rates are considerably higher in eastern than in western Europe; Indoor air pollution from biological agents related to damp and mould increases the risk of respiratory disease in children and adults.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the strain of coronavirus that causes coronavirus disease (COVID), a respiratory uially known as coronavirus, it was previously referred to by its provisional name novel coronavirus (nCoV).

As described by the National Institutes of Health, it is the successor to SARS-CoV   But only in the past years is the major evolution of respiratory therapy been realized. The History of Respiratory Therapy: Discovery and Evolution is the first comprehensive written book on this subject and makes it a pioneer which officially documents information which is scattered throughout various resources.5/5(2).

Respiratory Society (ERS), the leading profes-sional association in Europe for respiratory medicine, and the European Lung Foundation (ELF), its public voice, considered it essential to publish a document providing an overview of the ever-increasing impact lung disease is hav-ing on the lives of all Europeans.

The European Lung White Book, whichCited by: 2. The European Respiratory Society (ERS) and European Lung Foundation (ELF) “Lung Health in Europe Facts and Figures” provides an accessible and reliable summary of the state of lung health in Europe. At a first glance, the problems appear insurmountable.

Respiratory disease causes about 1 million deaths. A realistic look at treating respiratory diseases. Clinical Manifestations and Assessment of Respiratory Disease, 8 th Edition gives you a fundamental knowledge and understanding that is required to successfully assess and treat patients with respiratory diseases.

Using a unique organization of material, this full-color text is divided into three distinct areas Pages: In addition to these publications, the ERS publishes the European Lung White Book - a survey of the impact of respiratory disease across Europe, and has published the one-off booklets Air Quality and Health and the European Respiratory Roadmap as well as the European COPD Audit Report and reports on global respiratory health, published on Headquarters: Lausanne (Switzerland).

BMA Medical Book Awards Highly Commended in Internal Medicine. Clinical Respiratory Medicine provides practical guidance to help you more effectively diagnose and manage the full range of pulmonary disorders, including those seen in today’s most challenging patient populations.

Now with over brand-new review questions and 25 videos available online. The book Respiratory Diseases brings practical aspects of pulmonary diseases. It contains the result of years of experience through expert clinicians in this field from different scientific centers. The respiratory diseases are discussed according to epidemiology, pathology, diagnosis, treatment, and prognosis.

An important part of this book is dedicated to health economic aspects of lung disorders, as well as to the needs for improvements in direct patient care, in basic and clinical research, and in teaching and training.

Given that there is currently no central organisation dealing with respiratory disease monitoring in Europe, it is obvious that Cited by:   The burden of lung disease in Europe: data from the first European White Book R.

Loddenkemper, G.J. Gibson, Y. Sibille Breathe 1: ; DOI: /Cited by: 2. European Respiratory Journal. The ERJ is the official journal of the European Respiratory Society.

It publishes clinical and experimental work dealing with the whole field of respiratory medicine, including lung cell biology, epidemiology, immunology, pathophysiology, thoracic imaging, paediatric pneumology, occupational medicine, intensive care, sleep medicine, and thoracic.

Europe PMC is an ELIXIR Core Data Resource Learn more >. Europe PMC is a service of the Europe PMC Funders' Group, in partnership with the European Bioinformatics Institute; and in cooperation with the National Center for Biotechnology Information at the U.S. National Library of Medicine (NCBI/NLM).It includes content provided to the PMC International archive by.

Airway and Respiratory Management of the Suspected COVID Patient This document is largely borrowed based on SARS based evidence, case series data from China and Europe, and from national expert opinion. (Internet Book of Critical Care) Respiratory Medication Therapy 1.* Elsevier is a leading publisher of health science books and journals, helping to advance medicine by delivering superior education, reference information and decision support tools to doctors, nurses, health practitioners and students.Respiratory diseases unrelated to tobacco exhibit considerable geographical variation in national prevalence rates even within Europe, which is taken as an illustrative example, using the European Lung White Book data.

World wide, the variations and disease mix may be even more widely divergent. Of necessity, each will be discussed here briefly.